Since its first FDA approval in 2014, Merck’s Keytruda® (pembrolizumab) has been delivering results for treating a wide range of cancers. It received FDA approvals…
The U.S. Food and Drug Administration (FDA) first approved Janssen Biotech’s Remicade® (infliximab) in April of 1998 for the treatment of Crohn’s disease. It was…
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to manage new drugs. Our clinical and trade relations teams keep a keen…
